Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study-Reference-Cited by-同舟云学术

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

Published:2015-06-18 Issue:25 Volume:125 Page:3956-3962
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Wang Yu¹,Liu Qi-Fa²,Xu Lan-Ping¹,Liu Kai-Yan¹,Zhang Xiao-Hui¹,Ma Xiao³,Fan Zhi-Ping²,Wu De-Pei³,Huang Xiao-Jun¹⁴

Affiliation:

1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China;

2. Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China;

3. The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; and

4. Peking-Tsinghua Center for Life Sciences, Beijing, China

Abstract

Key Points Haploidentical transplant achieves outcomes similar to those of identical-sibling transplant for AML patients in first remission. Haploidentical transplant is a valid postremission treatment of intermediate- or high-risk AML patients lacking an identical donor.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/125/25/3956/1386704/3956.pdf

Reference38 articles.

1. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.;Döhner;Blood,2010

3. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?;Cornelissen;Blood,2007

4. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.;Schlenk;J Clin Oncol,2010

5. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.;Koreth;JAMA,2009

Cited by 368 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic hematopoietic cell transplantation from alternative donors in acute myeloid leukemia;Annals of Hematology;2024-08-17

2. Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation;British Journal of Haematology;2024-08-04

3. A simple predictor for donor‐specific anti‐HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation;HLA;2024-08

4. Patients Beyond the Optimal Range of rATG-AUC Still Benefit from the Targeted Dosing Strategy in Unmanipulated Haplo-PBSCT;Transplantation and Cellular Therapy;2024-08

5. Profile of Dr. Xiao-Jun Huang;Science China Life Sciences;2024-07-29